← Open Payments lookup

JEFFREY KRUPA: Open Payments

NPI 1215646724 · WASHINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,580 in 55 payments from 8 companies in 2025. Trend: 2023 $303 · 2024 $924 · 2025 $1,580

Food & beverage: $1,468Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.17$374
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$286
Janssen Pharmaceuticals, Inc11$267
Axsome Therapeutics, Inc.3$260
Neurocrine BioSciences, Inc.12$245
Otsuka America Pharmaceutical, Inc.5$77
ABBVIE INC.2$52
Supernus Pharmaceuticals, Inc.1$18

Products named: CAPLYTA, INVEGA SUSTENNA, Auvelity, INGREZZA, AUSTEDO XR, UZEDY, ABILIFY MAINTENA, VRAYLAR.

Industry payments across NJ — which companies pay providers there.